SCHEMBL1504531

SCHEMBL1504531

CN[C@@H](CCCNC(N)=S)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
C3AR1 Q16581 1/20 0.36
SIRT5 Q9NXA8 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
CACNA1B Q00975 2/20 0.35
NOD1 Q9Y239 2/20 0.35
OTC P00480 1/20 0.34
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
DDAH1 O94760 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.32
GNPAT O15228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30404095 0.86 C3AR1 (0.47) FOLH1C3AR1MEN1GAAKMT2A
SCHEMBL93364 0.86 C3AR1 (0.47) FOLH1C3AR1MEN1GAAKMT2A
SCHEMBL93363 0.86 C3AR1 (0.47) FOLH1C3AR1MEN1GAAKMT2A
SCHEMBL2762951 0.83 FOLH1 (0.39) FOLH1SMN1; SMN2C3AR1SIRT5MEN1
SCHEMBL93472 0.83 FOLH1 (0.38) FOLH1SMN1; SMN2C3AR1MEN1GAA
SCHEMBL162756 0.83 FOLH1 (0.38) FOLH1SMN1; SMN2C3AR1MEN1GAA
SCHEMBL93473 0.83 FOLH1 (0.38) FOLH1SMN1; SMN2C3AR1MEN1GAA
SCHEMBL17769024 0.83 FOLH1 (0.38) FOLH1SMN1; SMN2C3AR1MEN1GAA
SCHEMBL9115230 0.82 NOD1 (0.41) FOLH1SMN1; SMN2C3AR1MEN1GAA
Hydrochloric Acid SCHEMBL974818 0.81 FOLH1 (0.37) FOLH1SMN1; SMN2C3AR1MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110396-A1 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA Universiteit Maastricht (NL) 2023-01-04 EP claimed
WO-2013004716-A1 PEPTIDE BEADS UNIVERSITÄT BASEL (CH) 2013-01-10 WO claimed
EP-2539434-A1 GAMETES SEPARATION METHODS, COMPOSITIONS AND USES THEREOF Assistance Publique - Hôpitaux de Paris (FR) 2013-01-02 EP claimed
WO-2011104336-A1 GAMETES SEPARATION METHODS, COMPOSITIONS AND USES THEREOF ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) 2011-09-01 WO claimed
WO-2011032000-A2 METHOD FOR PROTECTION OF ANTIMICROBIAL AND ANTICANCER DRUGS FROM INACTIVATION BY NITRIC OXIDE NEW YORK UNIVERSITY (US) 2011-03-17 WO claimed
WO-2004084827-A2 REDUCTION OF ZINC-INDUCED NEUROTOXIC INJURY BY BLOCKADE OF NITRIC OXIDE SYNTHESIS NEUROBIOTEX, INC. (US) 2004-10-07 WO claimed
EP-1011656-A2 A METHOD FOR TREATING TENSION-TYPE HEADACHE Head Explorer ApS (DK) 2000-06-28 EP claimed
WO-1998019674-A2 A METHOD FOR TREATING TENSION-TYPE HEADACHE HEAD EXPLORER APS (DK) 1998-05-14 WO claimed
WO-2024006841-A2 COMPOSITIONS FOR WEIGHT LOSS AND CANCER TREATMENT KNOWLEDGE PHARMACEUTICALS INC. (US) 2024-01-04 WO disclosed
EP-4110396-A1 THERAPEUTIC COMBINATION FOR THE TREATMENT OF BRAIN ISCHEMIA AND SAID THERAPEUTIC COMBINATION FOR USE IN THE TREATMENT OF BRAIN ISCHEMIA Universiteit Maastricht (NL) 2023-01-04 EP disclosed
EP-3615084-A1 MEMBRANE ACTIVE MOLECULES Branequest, Inc. (US) 2020-03-04 EP disclosed
WO-2018200412-A1 MEMBRANE ACTIVE MOLECULES BraneQuest, Inc. (US) 2018-11-01 WO disclosed
CN-108367043-A The conjugate of quaternized tubulysin compound 西雅图基因公司 2018-08-03 CN disclosed
WO-2016149386-A1 BIOMARKERS FOR MALARIA DIAGNOSIS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2016-09-22 WO disclosed
EP-1132082-A1 Use of substances capable of blocking the production of glutamate for treating tension-type headache Head Explorer ApS (DK) 2001-09-12 EP disclosed
US-6284794-B1 Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase HEAD EXPLORER APS (DK) 2001-09-04 US disclosed
WO-2000048591-A1 COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING ANGIOGENESIS ANGIOGENE PHARMACEUTICALS LTD. (GB) 2000-08-24 WO disclosed
EP-1011656-A2 A METHOD FOR TREATING TENSION-TYPE HEADACHE Head Explorer ApS (DK) 2000-06-28 EP disclosed
WO-1998019674-A2 A METHOD FOR TREATING TENSION-TYPE HEADACHE HEAD EXPLORER APS (DK) 1998-05-14 WO disclosed
WO-1995013804-A1 S-ALKYL-ISOTHIOUREIDO-AMINO ACIDS AND USE THEREOF THE MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) 1995-05-26 WO disclosed